[Practical application of ophthalmic nutraceuticals in patients with dry form of age-related macular degeneration].

Erika Eskina A V Belogurova A A Gvetadze A S Smorchkova

Published in: Vestnik oftalmologii (2020)

The drug Complex corresponding to the AREDS 2 formula contributes to a significant increase in MPOD, improvements of visual functions and overall antioxidant status of patients, which confirms the feasibility of its use in patients with dry AMD.

Keyphrases

age related macular degeneration
end stage renal disease
ejection fraction
newly diagnosed
chronic kidney disease
prognostic factors
peritoneal dialysis
emergency department
patient reported outcomes
human milk
patient reported
low birth weight